2018
Survival of syngeneic and allogeneic iPSC–derived neural precursors after spinal grafting in minipigs
STRNADEL, Jan; Cassiano CARROMEU; Cedric BARDY; Michael NAVARRO; Oleksandr PLATOSHYN et. al.Základní údaje
Originální název
Survival of syngeneic and allogeneic iPSC–derived neural precursors after spinal grafting in minipigs
Autoři
STRNADEL, Jan; Cassiano CARROMEU; Cedric BARDY; Michael NAVARRO; Oleksandr PLATOSHYN; Andreas N. GLUD; Silvia MARSALA; Jozef KAFKA; Atsushi MIYANOHARA; Tomohisa KATO JR.; Takahiro TADOKORO; Michael P. HEFFERAN; Kota KAMIZATO; Tetsuya YOSHIZUMI; Stefan JUHAS; Jana JUHASOVA; Chak-Sum HO; Taba KHERADMAND; PeiXi CHEN; Dáša BOHAČIAKOVÁ; Marian HRUSKA-PLOCHAN; Andrew J. TODD; Shawn P. DRISCOLL; Thomas D. GLENN; Samuel L. PFAFF; Jiri KLIMA; Joseph CIACCI; Eric CURTIS; Fred H. GAGE; Jack BUI; Kazuhiko YAMADA; Alysson R. MUOTRI a Martin MARSALA
Vydání
Science Translational Medicine, Washington, American Association for the Advancement of Science, 2018, 1946-6234
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
10601 Cell biology
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 17.200
Kód RIV
RIV/00216224:14110/18:00102732
Organizační jednotka
Lékařská fakulta
UT WoS
000431766400001
EID Scopus
2-s2.0-85047080924
Klíčová slova anglicky
cells derived; iPSC
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 10. 2. 2019 19:54, Soňa Böhmová
Anotace
V originále
The use of autologous (or syngeneic) cells derived from induced pluripotent stem cells (iPSCs) holds great promise for future clinical use in a wide range of diseases and injuries. It is expected that cell replacement therapies using autologous cells would forego the need for immunosuppression, otherwise required in allogeneic transplantations. However, recent studies have shown the unexpected immune rejection of undifferentiated autologous mouse iPSCs after transplantation. Whether similar immunogenic properties are maintained in iPSC-derived lineage-committed cells (such as neural precursors) is relatively unknown. We demonstrate that syngeneic porcine iPSC-derived neural precursor cell (NPC) transplantation to the spinal cord in the absence of immunosuppression is associated with long-term survival and neuronal and glial differentiation. No tumor formation was noted. Similar cell engraftment and differentiation were shown in spinally injured transiently immunosuppressed swine leukocyte antigen (SLA)–mismatched allogeneic pigs. These data demonstrate that iPSC-NPCs can be grafted into syngeneic recipients in the absence of immunosuppression and that temporary immunosuppression is sufficient to induce long-term immune tolerance after NPC engraftment into spinally injured allogeneic recipients. Collectively, our results show that iPSC-NPCs represent an alternative source of transplantable NPCs for the treatment of a variety of disorders affecting the spinal cord, including trauma, ischemia, or amyotrophic lateral sclerosis.